PAINREFORM

PainReform is a specialty pharmaceutical company that develops products for the treatment of pain. Focused on reformulations of established pain drugs for the US FDA 505(b)(2) regulatory pathway, PainReform applies unique technologies to enhance efficacy, reduce adverse effects and increase convenience as well as faster return of motor function.
PAINREFORM
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
Herzliya, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.painreform.com
Total Employee:
1+
Status:
Active
Contact:
97299542266
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
More informations about "PainReform"
company-profile - painreform
Company profile We are a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics Our proprietary extended-release drug-delivery โฆSee details»
Investors - painreform
5 days ago Investor relations We are a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics Our proprietary extended release drug-delivery system is designed to provide an extended โฆSee details»
PainReform - Crunchbase Company Profile & Funding
PainReform is a specialty pharmaceutical company that develops products for the treatment of pain. Focused on reformulations of established pain drugs for the US FDA 505(b)(2) regulatory โฆSee details»
PainReform Ltd. (PRFX) Company Profile & Facts - Yahoo Finance
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in โฆSee details»
PainReform (PRFX) Company Profile & Description - Stock Analysis
4 days ago PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical โฆSee details»
PainReform - Org Chart, Teams, Culture & Jobs - The Org
PainReform. Join to edit. Join to edit. PainReform Ltd is a phamaceutical company that specializes in the reformulation of current pain medications to benefit the patient better. โฆSee details»
PainReform - Israeli Startup | Startup Nation Finder
Mar 6, 2025 PainReform is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics. Its proprietary drug-delivery system is designed to โฆSee details»
PainReform - 2025 Company Profile, Funding & Competitors
Mar 5, 2025 Painreform is a specialty pharmaceutical company that develops products for the treatment of pain. It is focused on reformulations of established pain drugs by applying unique โฆSee details»
PainReform - businessabc
Mar 20, 2025 PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in โฆSee details»
PainReform - Products, Competitors, Financials, Employees, โฆ
PainReform is a clinical stage specialty pharmaceutical company involved in the reformulation of established therapeutics within the pain management sector. Use the CB Insights Platform to โฆSee details»
PainReform Provides Year-End Business Update; on Track to โฆ
Mar 17, 2022 PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022 โฆSee details»
PainReform 2025 Company Profile: Stock Performance & Earnings
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the โฆSee details»
PainReform - Craft
PainReform is a pharmaceutical company that develops products for the treatment of pain. Its extended release drug-delivery system is designed to provide an extended period of post โฆSee details»
PainReform - Overview, News & Similar companies | ZoomInfo.com
Jun 15, 2023 PainReform is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics. PRF-110, the Company's lead product, is based on โฆSee details»
PainReform Provides Year-End Business Update; On track to โฆ
Tel Aviv, Israel โ March 17, 2022 โ PainReform Ltd. (Nasdaq: PRFX) (โPainReformโ or the โCompanyโ), a clinical-stage specialty pharmaceutical company focused on the reformulation โฆSee details»
PainReform Provides Year-End Business Update and Reports
Mar 18, 2021 Ilan Hadar, Chief Executive Officer of PainReform, commented, โWe are making rapid progress towards commencing our Phase 3 clinical trials of PRF-110. Our first planned โฆSee details»
Possible New Era in Pain Management: FDA Approves Novel Non โฆ
Apr 15, 2025 The Institute for Clinical and Economic Review, a nonprofit organization that evaluates prescription drug cost-effectiveness, has suggested that the drug could be only โฆSee details»
PainReform Provides Business Update for the Third Quarter of โฆ
Reports continued progress towards commencing Phase 3 clinical trials. Announces Selection of Pharmaceutics International, Inc. as U.S. Manufacturer of PRF-110 for Upcoming Phase 3 โฆSee details»
Inside the Battle Over OpenAIโs Corporate Restructuring
5 days ago Aguilarโs new organization, LatinoProsperity, focuses on intergenerational wealth building, and he believed cutting-edge AI chatbots such as ChatGPT would become an โฆSee details»
press releases - painreform
Nov 20, 2024 PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics. read more. 02/18/2025. PainReform Executes โฆSee details»